These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12499928)

  • 1. A 43-year-old man was admitted to the hospital with the diagnosis of acute pancreatitis of 4 days' duration.
    Wordliczek J; Serednicki W; Grabowska I; Szczepanik AM; Nowak W; Popiela T
    Pancreas; 2003 Jan; 26(1):101-2. PubMed ID: 12499928
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of recombinant factor VIIa in the treatment of massive retroperitoneal bleeding due to severe necrotizing pancreatitis.
    Stefanović B; Stefanović B; Mijatović S; Radenković D; Popović N; Sijacki A; Lacković V
    Vojnosanit Pregl; 2009 Nov; 66(11):928-32. PubMed ID: 20017427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of bleeding in severe necrotizing pancreatitis with recombinant factor VIIa.
    Svartholm E; Annerhagen V; Länne T
    Anesthesiology; 2002 Jun; 96(6):1528. PubMed ID: 12170074
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of recombinant factor VIIa for life-threatening bleeding in a patient with severe necrotizing pancreatitis.
    Borrás-Blasco J; Conesa-García V; Navarro-Ruiz A; Palacios-Ortega F; Gómez A
    Pancreas; 2005 Oct; 31(3):292-4. PubMed ID: 16163065
    [No Abstract]   [Full Text] [Related]  

  • 5. [Haemorrhagic shock complicating acute pancreatitis].
    Duszyńiska W; Lipińska-Gediga M; Domosławski P; Kaiser T; Durek G; Bednarz W
    Anestezjol Intens Ter; 2011; 43(1):36-9. PubMed ID: 21786529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal acute necrohaemorrhagic pancreatitis with massive intraperitoneal and retroperitoneal bleeding: a rare cause of exsanguination.
    Querido S; Carvalho I; Moleiro F; Póvoa P
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant activated factor VII for bleeding in pancreatitis: a case series.
    Laffan MA; Tait RC; Blatný J; Espersen K; Grabowska I; Loch-Bakoñska L; Pauzkowska A; Stasiak-Pikula E; Michalska G; Wendon J; Piotrowska K
    Pancreas; 2005 Apr; 30(3):279-84. PubMed ID: 15782108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient.
    Holcomb JB; Neville HL; Fischer CF; Hoots K
    Curr Surg; 2003; 60(4):423-7. PubMed ID: 14972234
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multiple complications of acute destructive pancreatitis].
    Ziginova TM; Fetiukov AI; Zotov PS; Kovchur OI
    Vestn Khir Im I I Grek; 2008; 167(6):123-4. PubMed ID: 19241834
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant factor VIIa treatment of bleeding associated with acute renal failure.
    Moisescu E; Ardelean L; Simion I; Mureşan A; Ciupan R
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):575-7. PubMed ID: 10997798
    [No Abstract]   [Full Text] [Related]  

  • 11. The latest in trauma nursing.
    Doherty D
    Nurs Manage; 2003; 34 Suppl Critical():19. PubMed ID: 12891082
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of traumatic bleeding with recombinant factor VIIa.
    Kenet G; Walden R; Eldad A; Martinowitz U
    Lancet; 1999 Nov; 354(9193):1879. PubMed ID: 10584732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, randomized, controlled study to explore the efficacy of rFVIIa on intraoperative blood loss and mortality in patients with severe acute pancreatitis.
    Lu J; Liao LM; Geng YX; Wang X; Tong ZH; Ke L; Li WQ; Li N; Li JS
    Thromb Res; 2014 Apr; 133(4):574-8. PubMed ID: 24457144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recombinant activated Factor VII (Novo Seven) for uncontrollable hemorrhage in critically ill patients with multiple injuries].
    Pernazza F; Olearis A
    Minerva Chir; 2004 Apr; 59(2):XVII-XIX. PubMed ID: 15455479
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy.
    Chuansumrit A; Nuntnarumit P; Okascharoen C; Teeraratkul S; Suwansingh S; Supapannachart S
    Pediatrics; 2002 Jul; 110(1 Pt 1):169-71. PubMed ID: 12093965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant factor VIIa in severe uremic bleeding.
    Révész T; Arets B; Bierings M; van den Bos C; Duval E
    Thromb Haemost; 1998 Aug; 80(2):353. PubMed ID: 9716175
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of bleeding with recombinant factor VIIa in a patient with extensive burns.
    Bianchi A; Jackson D; Maitz P; Thanakrishnan G
    Thromb Haemost; 2004 Jan; 91(1):203-4. PubMed ID: 14691589
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant factor VIIa use following massive pulmonary hemorrhage after CPB.
    Courtney H
    Paediatr Anaesth; 2009 Mar; 19(3):272. PubMed ID: 19236650
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention and treatment of major blood loss.
    Mannucci PM; Levi M
    N Engl J Med; 2007 May; 356(22):2301-11. PubMed ID: 17538089
    [No Abstract]   [Full Text] [Related]  

  • 20. Spontaneous liver hemorrhage during laparotomy for necrotizing enterocolitis: a potential role for recombinant factor VIIa.
    Filan PM; Mills JF; Clarnette TD; Ekert H; Ekert P
    J Pediatr; 2005 Dec; 147(6):857-9. PubMed ID: 16356448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.